IONCTURA

Founded in June 2017, iOnctura is a clinical stage biopharmaceutical company focused on delivering innovative cancer treatments to patients with unmet medical need... iOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patients with unmet medical need. Company developing molecules that individually harness the combined effect of immune-mediated and direct anti-tumour activity. Drug research is on identifying and harnessing new insights into the tumour immunology of established targets. iOnctura differentiates itself by progressing best-in-class molecules that bind their targets in a novel way, allowing for precise exploitation of these newly established mechanisms of action.

Also known as: iOnctura BV, iOnctura SA

Primary location: Amsterdam Netherlands